An open-label feasibility trial of transdermal cannabidiol for hand osteoarthritis

An open-label feasibility trial of transdermal cannabidiol for hand osteoarthritis

Hand osteoarthritis (OA) is an irreversible degenerative condition causing chronic pain and impaired functionality. Existing treatment options are often inadequate. Cannabidiol (CBD) has demonstrated analgesic and anti-inflammatory effects in preclinical models of arthritis. In this open-label feasibility trial, participants with symptomatically active hand OA applied a novel transdermal CBD gel (4% w/w) three times a day for four weeks to their…

The Israeli company InnoCan Pharma, specialized in cannabis-based therapies, has announced that its injections of CBD (cannabidiol) demonstrated a great effectiveness in the relief of pain in dogs with naturally occurring osteoarthritis.This advance could mark a milestone in the treatment of chronic diseases in animals.According to the results of the studies carried out, the long-term treatment with LPT-CBD injection showed a remarkable reductio…

Study: CBD Strengthens Peyer’s Patch Barrier, Suggesting Potential to Help Prevent Gut Inflammation

The Marijuana Herald - Marijuana news and information According to the results of a new study, cannabidiol (CBD) significantly strengthens the epithelial barrier in Peyer’s Patches and may support the prevention of inflammation-related conditions. Conducted by researchers at Freie Universität Berlin and the University of Jordan, the study examined the effects of CBD on intestinal tissues using an ex vivo porcine model. Researchers focused on two…

CBD proves its value for chronic pain relief in small survey study

New research has shown that cannabidiol (CBD) can be beneficial for relieving chronic pain.

CBD Helped Relieve Chronic Pain In More Than 98% Of Patients, Newly Published Study Finds

. . .